Annual Working Capital
$264.22 M
+$149.15 M+129.61%
31 December 2023
Summary:
TG Therapeutics annual working capital is currently $264.22 million, with the most recent change of +$149.15 million (+129.61%) on 31 December 2023. During the last 3 years, it has fallen by -$259.96 million (-49.59%). TGTX annual working capital is now -49.59% below its all-time high of $524.19 million, reached on 31 December 2020.TGTX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$448.95 M
+$168.47 M+60.06%
30 September 2024
Summary:
TG Therapeutics quarterly working capital is currently $448.95 million, with the most recent change of +$168.47 million (+60.06%) on 30 September 2024. Over the past year, it has increased by +$187.52 million (+71.73%). TGTX quarterly working capital is now -14.35% below its all-time high of $524.19 million, reached on 31 December 2020.TGTX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TGTX Working Capital Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +129.6% | +71.7% |
3 y3 years | -49.6% | +58.0% |
5 y5 years | +557.6% | +10000.0% |
TGTX Working Capital High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -49.6% | +129.6% | at high | +290.1% |
5 y | 5 years | -49.6% | +557.6% | -14.3% | >+9999.0% |
alltime | all time | -49.6% | >+9999.0% | -14.3% | +9230.3% |
TG Therapeutics Working Capital History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $448.95 M(+60.1%) |
June 2024 | - | $280.49 M(+7.5%) |
Mar 2024 | - | $260.90 M(-1.3%) |
Dec 2023 | $264.22 M(+129.6%) | $264.22 M(+1.1%) |
Sept 2023 | - | $261.44 M(+92.4%) |
June 2023 | - | $135.91 M(+11.7%) |
Mar 2023 | - | $121.71 M(+5.8%) |
Dec 2022 | $115.07 M(-56.7%) | $115.07 M(-21.4%) |
Sept 2022 | - | $146.47 M(-8.0%) |
June 2022 | - | $159.23 M(-15.1%) |
Mar 2022 | - | $187.56 M(-29.4%) |
Dec 2021 | $265.58 M(-49.3%) | $265.58 M(-6.5%) |
Sept 2021 | - | $284.12 M(-22.7%) |
June 2021 | - | $367.52 M(-16.9%) |
Mar 2021 | - | $442.52 M(-15.6%) |
Dec 2020 | $524.19 M(+710.2%) | $524.19 M(+187.0%) |
Sept 2020 | - | $182.66 M(-14.4%) |
June 2020 | - | $213.40 M(+757.1%) |
Mar 2020 | - | $24.90 M(-61.5%) |
Dec 2019 | $64.70 M(+61.0%) | $64.70 M(>+9900.0%) |
Sept 2019 | - | $158.00 K(-99.6%) |
June 2019 | - | $38.47 M(-12.8%) |
Mar 2019 | - | $44.12 M(+9.8%) |
Dec 2018 | $40.18 M(-38.5%) | $40.18 M(-42.2%) |
Sept 2018 | - | $69.50 M(-29.9%) |
June 2018 | - | $99.10 M(+18.5%) |
Mar 2018 | - | $83.61 M(+27.9%) |
Dec 2017 | $65.36 M(+92.3%) | $65.36 M(-16.1%) |
Sept 2017 | - | $77.87 M(+2.1%) |
June 2017 | - | $76.29 M(-23.1%) |
Mar 2017 | - | $99.24 M(+192.0%) |
Dec 2016 | $33.99 M(-55.5%) | $33.99 M(-37.6%) |
Sept 2016 | - | $54.45 M(-1.8%) |
June 2016 | - | $55.43 M(-10.1%) |
Mar 2016 | - | $61.68 M(-19.2%) |
Dec 2015 | $76.34 M(-4.7%) | $76.34 M(-19.7%) |
Sept 2015 | - | $95.04 M(+0.6%) |
June 2015 | - | $94.52 M(-11.0%) |
Mar 2015 | - | $106.19 M(+32.6%) |
Dec 2014 | $80.09 M(+122.6%) | $80.09 M(+18.2%) |
Sept 2014 | - | $67.76 M(+45.2%) |
June 2014 | - | $46.68 M(-14.0%) |
Mar 2014 | - | $54.30 M(+50.9%) |
Dec 2013 | $35.99 M(+121.3%) | $35.99 M(-19.9%) |
Sept 2013 | - | $44.94 M(+319.8%) |
June 2013 | - | $10.70 M(-30.1%) |
Mar 2013 | - | $15.32 M(-5.8%) |
Dec 2012 | $16.26 M(+97.6%) | $16.26 M(+0.4%) |
Sept 2012 | - | $16.20 M(-10.5%) |
June 2012 | - | $18.11 M(-8.5%) |
Mar 2012 | - | $19.78 M(+140.4%) |
Dec 2011 | $8.23 M(-439.5%) | $8.23 M(-784.6%) |
Sept 2011 | - | -$1.20 M(-62.1%) |
June 2011 | - | -$3.17 M(+29.5%) |
Mar 2011 | - | -$2.45 M(+1.1%) |
Dec 2010 | -$2.42 M | -$2.42 M(-17.5%) |
Sept 2010 | - | -$2.94 M(-5.2%) |
Date | Annual | Quarterly |
---|---|---|
June 2010 | - | -$3.10 M(-36.9%) |
Mar 2010 | - | -$4.92 M(+116.8%) |
Dec 2009 | -$2.27 M(+270.6%) | -$2.27 M(+67.0%) |
Sept 2009 | - | -$1.36 M(+6.8%) |
June 2009 | - | -$1.27 M(+551.1%) |
Mar 2009 | - | -$195.40 K(-68.1%) |
Dec 2008 | -$612.10 K(-39.2%) | -$612.10 K(-67.8%) |
Sept 2008 | - | -$1.90 M(+151.9%) |
June 2008 | - | -$755.20 K(+79.9%) |
Mar 2008 | - | -$419.80 K(-58.3%) |
Dec 2007 | -$1.01 M(-174.5%) | -$1.01 M(-326.8%) |
Sept 2007 | - | $443.70 K(-83.0%) |
June 2007 | - | $2.61 M(-62.7%) |
Mar 2007 | - | $7.00 M(+418.3%) |
Dec 2006 | $1.35 M(-85.6%) | $1.35 M(-64.0%) |
Sept 2006 | - | $3.75 M(-29.3%) |
June 2006 | - | $5.31 M(-22.5%) |
Mar 2006 | - | $6.86 M(-26.8%) |
Dec 2005 | $9.36 M(+119.6%) | $9.36 M(-15.6%) |
Sept 2005 | - | $11.09 M(+1053.2%) |
June 2005 | - | $961.70 K(-65.6%) |
Mar 2005 | - | $2.80 M(-34.4%) |
Dec 2004 | $4.26 M(-37.5%) | $4.26 M(-28.4%) |
Sept 2004 | - | $5.96 M(-28.0%) |
June 2004 | - | $8.27 M(-9.7%) |
Mar 2004 | - | $9.16 M(+34.2%) |
Dec 2003 | $6.82 M(+969.9%) | $6.82 M(-935.2%) |
Sept 2003 | - | -$817.20 K(+50.7%) |
June 2003 | - | -$542.10 K(-492.5%) |
Mar 2003 | - | $138.10 K(-78.4%) |
Dec 2002 | $637.90 K(-43.1%) | $637.90 K(-1471.8%) |
Sept 2002 | - | -$46.50 K(-108.9%) |
June 2002 | - | $524.30 K(+11.9%) |
Mar 2002 | - | $468.60 K(-58.2%) |
Dec 2001 | $1.12 M(+40.4%) | $1.12 M(-499.8%) |
Sept 2001 | - | -$280.60 K(-184.2%) |
June 2001 | - | $333.30 K(-81.8%) |
Mar 2001 | - | $1.83 M(+129.3%) |
Dec 2000 | $798.70 K(-75.8%) | $798.70 K(-53.4%) |
Sept 2000 | - | $1.71 M(-10.9%) |
June 2000 | - | $1.92 M(-35.4%) |
Mar 2000 | - | $2.98 M(-9.8%) |
Dec 1999 | $3.30 M(-41.1%) | $3.30 M(-13.2%) |
Sept 1999 | - | $3.80 M(-7.3%) |
June 1999 | - | $4.10 M(-12.8%) |
Mar 1999 | - | $4.70 M(-16.1%) |
Dec 1998 | $5.60 M(-30.9%) | $5.60 M(-17.6%) |
Sept 1998 | - | $6.80 M(-13.9%) |
June 1998 | - | $7.90 M(+14.5%) |
Mar 1998 | - | $6.90 M(-14.8%) |
Dec 1997 | $8.10 M(+305.0%) | $8.10 M(-15.6%) |
Sept 1997 | - | $9.60 M(+380.0%) |
June 1997 | - | $2.00 M(+66.7%) |
Mar 1997 | - | $1.20 M(-40.0%) |
Dec 1996 | $2.00 M | $2.00 M(-33.3%) |
Sept 1996 | - | $3.00 M(+25.0%) |
June 1996 | - | $2.40 M |
FAQ
- What is TG Therapeutics annual working capital?
- What is the all time high annual working capital for TG Therapeutics?
- What is TG Therapeutics annual working capital year-on-year change?
- What is TG Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for TG Therapeutics?
- What is TG Therapeutics quarterly working capital year-on-year change?
What is TG Therapeutics annual working capital?
The current annual working capital of TGTX is $264.22 M
What is the all time high annual working capital for TG Therapeutics?
TG Therapeutics all-time high annual working capital is $524.19 M
What is TG Therapeutics annual working capital year-on-year change?
Over the past year, TGTX annual working capital has changed by +$149.15 M (+129.61%)
What is TG Therapeutics quarterly working capital?
The current quarterly working capital of TGTX is $448.95 M
What is the all time high quarterly working capital for TG Therapeutics?
TG Therapeutics all-time high quarterly working capital is $524.19 M
What is TG Therapeutics quarterly working capital year-on-year change?
Over the past year, TGTX quarterly working capital has changed by +$187.52 M (+71.73%)